Literature DB >> 22899432

The comparison of genetic variation in the envelope protein between various immunodeficiency viruses and equine infectious anemia virus.

Qing Yuan1, Chang Liu, Zhipin Liang, Xueqing Chen, Danhong Diao, Xiaohong Kong.   

Abstract

The envelope protein (Env) of lentiviruses such as HIV, SIV, FIV and EIAV is larger than that of other retroviruses. The Chinese EIAV attenuated vaccine is based on Env and has helped to successfully control this virus, demonstrating that envelope is crucial for vaccine. We compared Env variation of the four kinds of lentiviruses. Phylogenetic analysis showed that the evolutionary relationship of Env between HIV and SIV was the closest and they appeared to descend from a common ancestor, and the relationship of HIV and EIAV was the furthest. EIAV had the shortest Env length and the least number of potential N-linked glycosylation sites (PNGS) as well as glycosylation density compared to various immunodeficiency viruses. However, HIV had the longest Env length and the most PNGS. Moreover, the alignment of HIV and SIV showed that PNGS were primarily distributed within extracellular membrane protein gp120 rather than transmembrane gp41. It implies that the size difference among these viruses is associated with a lentivirus specific function and also the diversity of env. There are low levels of modification of glycosylation sites of Env and selection of optimal protective epitopes might be useful for development of an effective vaccine against HIV/AIDS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22899432      PMCID: PMC8218065          DOI: 10.1007/s12250-012-3253-x

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  31 in total

Review 1.  Developments in preclinical AIDS vaccine efficacy models.

Authors:  W M Bogers; C Cheng-Mayer; R C Montelaro
Journal:  AIDS       Date:  2000       Impact factor: 4.177

Review 2.  HIV sequence databases.

Authors:  Carla Kuiken; Bette Korber; Robert W Shafer
Journal:  AIDS Rev       Date:  2003 Jan-Mar       Impact factor: 2.500

3.  HIV vaccine design and the neutralizing antibody problem.

Authors:  Dennis R Burton; Ronald C Desrosiers; Robert W Doms; Wayne C Koff; Peter D Kwong; John P Moore; Gary J Nabel; Joseph Sodroski; Ian A Wilson; Richard T Wyatt
Journal:  Nat Immunol       Date:  2004-03       Impact factor: 25.606

4.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.

Authors:  J D Thompson; T J Gibson; F Plewniak; F Jeanmougin; D G Higgins
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

5.  Location-specific, unequal contribution of the N glycans in simian immunodeficiency virus gp120 to viral infectivity and removal of multiple glycans without disturbing infectivity.

Authors:  S Ohgimoto; T Shioda; K Mori; E E Nakayama; H Hu; Y Nagai
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

6.  Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type 1 glycoprotein 120 by N-linked oligosaccharides in the V1 region.

Authors:  B Losman; A Bolmstedt; K Schønning; C Westin; E M Fenyö; S Olofsson
Journal:  AIDS Res Hum Retroviruses       Date:  2001-07-20       Impact factor: 2.205

7.  Restricted genetic diversity of HIV-1 subtype C envelope glycoprotein from perinatally infected Zambian infants.

Authors:  Hong Zhang; Damien C Tully; Federico G Hoffmann; Jun He; Chipepo Kankasa; Charles Wood
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

8.  Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin.

Authors:  Ming Zhang; Brian Gaschen; Wendy Blay; Brian Foley; Nancy Haigwood; Carla Kuiken; Bette Korber
Journal:  Glycobiology       Date:  2004-06-02       Impact factor: 4.313

9.  Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus.

Authors:  Susan L Payne; Xiao-fang Pei; Bin Jia; Angela Fagerness; Frederick J Fuller
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

10.  HIV-1 with multiple CCR5/CXCR4 chimeric receptor use is predictive of immunological failure in infected children.

Authors:  Mariangela Cavarelli; Ingrid Karlsson; Marisa Zanchetta; Liselotte Antonsson; Anna Plebani; Carlo Giaquinto; Eva Maria Fenyö; Anita De Rossi; Gabriella Scarlatti
Journal:  PLoS One       Date:  2008-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.